Rofail, D.(Diana Rofail)
patient treatment study tm patients health transfusion deferoxamine satisfaction therapy erasmus mc compliance disease score activity result deferiprone questionnaire iron chelation therapy problem thalassemia level italy chelation productivity infusion component hrqol italian outcome erasmu month blood regimen summary iron overload ithaca informa physician 08/29/11 complication table downloaded domain component summary score population consequence ict scalone resource e 1000 blood transfusions survival wellbeing sample value quality burden patient /month e 500 2 weeks hospital overload effect congress effectiveness estimate benefit chelation therapy time horizon center 3 years instance treatment satisfaction 1 patient period ithaca study scalone perception sf -36 scale employment
1 Most Recent Publications
Costs, quality of life, treatment satisfaction and compliance in patients with β-thalassemia major undergoing iron chelation therapy: The ITHACA study
Scalone, L. Mantovani, L.G. Prossomariti, L. Stefàno, I. Cappellini, M.D. Krol, H.M. Rofail, D. Ravera, S. Bisconte, M.G. Borgna-Pignatti, C. Borsellino, Z. Cianciulli, P. Gallisai, D.